High Risk Leukemia Fellowship

Overview

The High-Risk Leukemia/Lymphoma (HRLL) fellowship at Seattle Children's Hospital (SCH) is a dedicated, year-long program for trainees who have completed a pediatric hematology/oncology fellowship. This program provides comprehensive, multidisciplinary clinical and academic immersion in pediatric leukemia and hematopoietic cell transplantation (HCT).

Leveraging its broad national referral base, the HRLL program offers care for children with high-risk leukemias and lymphomas who require treatment plans beyond standard chemotherapy, including cellular immunotherapy, HCT, and novel targeted therapies.

Curriculum

Fellows gain significant experience with a wide range of oncology and HCT treatments, from established active therapies like hematopoietic cell transplantation (HCT) to early-phase and novel trial therapies.

A key component of the training is involvement in the conduct of early-phase (I and II) and Phase III clinical trials, including innovative pilots utilizing immunotherapeutic and molecularly driven clinical research. This collaboration between Seattle Children's, the Ben Towne Center for Childhood Cancer Research (BTCCR), and Fred Hutch Cancer Center—international leaders in disease biology and early-phase trials—provides exposure to cutting-edge basic and translational research.

Fellows will learn from faculty who lead local, national, and international trials and receive global consultation requests, gaining an understanding of clinical trial eligibility, enrollment, and patient management in diverse settings.

How to Apply

Eligibility Criteria:

American Board of Pediatrics certified or eligible in Pediatrics
Eligible to obtain a Washington State medical licensure
On-track to complete a pediatric hematology/oncology fellowship

Application Requirements:

Cover Letter, CV, Color Photo, 3 Letters of Reference

Applications will be accepted from January 1st of the year prior to appointment in July. (i.e. January 1st, 2026, for appointment commencing July 2027). Please contact Irene Harun with questions regarding your application.

Core Training Sites

Seattle Children's Hospital

Seattle Children's Hospital is both a community hospital for greater Seattle and the pediatric referral center for the Northwest providing excellent pediatric care to meet the medical, surgical and developmental needs of children in the WWAMI region (Washington, Wyoming, Alaska, Montana, and Idaho). Serving as the main clinical training site for pediatric residents, this 423-bed hospital is conveniently located 1.5 miles from the University of Washington campus in a residential neighborhood of Seattle. The staff consists of University faculty and Seattle Children's full-time physicians.

Additional Information

Fred Hutch Cancer Center

Fred Hutchinson Cancer Research Center (FHCRC)

Fred Hutch Cancer Center is one of the world's premiere research institutions, home to three Nobel Laureates (including Dr. Donnall Thomas, who was awarded the Nobel Prize in 1990 for his contributions to the field of bone marrow transplantation) and many other global leaders in life sciences research. The Center receives more research funding from the National Institutes of Health than any other public or private research institution in the world. The Hutchinson Center, together with its clinical and research partners, the University of Washington and Seattle Children's, comprise the Fred Hutch/University of Washington Cancer Consortium. The Consortium is among 40 National Cancer Institute-designated comprehensive cancer centers nationwide. More than 2,760 people work for the Hutchinson Center, including over 650 scientific faculty and more than 550 pre-doctoral and post-doctoral researchers and other scientific staff.

Faculty